EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact

John H Growdon, John C Morris, Ronald C Petersen, Mary Sano, Lon S Schneider

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 28.09.2026. Verfasst von John H Growdon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomedical Research. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the groundbreaking work of Alois Alzheimer in the early 1900s, Alzheimer's disease research has evolved immensely, most notably with the establishment of the Alzheimer's Disease Research Centers (ADRC). Fueled by the vision and funding of the National Institute on Aging (NIA), ADRCs have created a legacy through their work standardizing criteria for Alzheimer's disease diagnosis. Leveraging the experience of the Consortium to Establish a Registry for Alzheimer's Disease, the ADRCs advanced standardized assessment tools, including the Clinical and Neuropsychological Batteries, as well as the CDR, which would make way for uniform data collection, in what we know today as the National Alzheimer's Coordinating Center (NACC). Collaborative data collection was expanded by NIA to support the development of treatments for Alzheimer's disease and related disorders (ADRD) through the Alzheimer's Disease Cooperative Study (ADCS) and the Alzheimer's Clinical Trial Consortium (ACTC) programs. These NIA sponsored programs have created a foundation for today's pharmacological and non‐pharmacological interventions to improve cognition and function in persons living with ADRD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomedical ResearchHumansUnited StatesNational Institute on Aging (U.S.)

Stichwörter der Autor:innen

Alzheimer's Disease Research Center (ADRC)Clinical Dementia Rating (CDR)NIA research infrastructureNational Institute on Aging (NIA)center programclinical trialsmild cognitive impairment (MCI)

Autor:innen und Institutionen

  • Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Washington University School of Medicine, St Louis, Missouri, USA.
  • Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Growdon, J. H., Morris, J. C., Petersen, R. C., Sano, M., & Schneider, L. S. (2026). Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71694

Vancouver

Growdon JH, Morris JC, Petersen RC, Sano M, Schneider LS. Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71694

BibTeX
@article{Growdon2026,
  author = {Growdon, John H and Morris, John C and Petersen, Ronald C and Sano, Mary and Schneider, Lon S},
  title = {Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71694}
}
Kostenlos starten →